Norland signs lithotripsy agreement with Marconi:
This article was originally published in Clinica
Executive Summary
Marconi Medical Systems and Norland Medical Systems have signed a contract for Norland to distribute the Genestone 190 lithotripter, claimed by Norland to be the most affordable lithotripter of its kind available in the US today at less than $200,000. The company says that the US is lagging behind other developed countries regarding access to lithotripsy, "mainly due to poor price/performance ratio of existing systems that put them out of reach of community hospitals".
You may also be interested in...
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.